[
  {
    "ts": null,
    "headline": "Q1 earnings pulse check: companies tentative on pharma-specific tariffs",
    "summary": "Whilst 2025 outlooks include cost impacts from existing tariffs, companies have not adjusted their guidance for future pharma-specific ones.",
    "url": "https://finnhub.io/api/news?id=8389e80b43b1a1e15fe173a62350df2f497774f34feae334ca0c2d7c0764be08",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746198384,
      "headline": "Q1 earnings pulse check: companies tentative on pharma-specific tariffs",
      "id": 134204387,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Whilst 2025 outlooks include cost impacts from existing tariffs, companies have not adjusted their guidance for future pharma-specific ones.",
      "url": "https://finnhub.io/api/news?id=8389e80b43b1a1e15fe173a62350df2f497774f34feae334ca0c2d7c0764be08"
    }
  },
  {
    "ts": null,
    "headline": "These companies are emerging as potential winners in Trump’s trade war",
    "summary": "These companies are emerging as potential winners in Trump’s trade war",
    "url": "https://finnhub.io/api/news?id=3730d7ab97a78fdc13b9ea1cffca7e0ca2138a8dc8596e145bce054cf7f1dd0e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746190920,
      "headline": "These companies are emerging as potential winners in Trump’s trade war",
      "id": 134193184,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "These companies are emerging as potential winners in Trump’s trade war",
      "url": "https://finnhub.io/api/news?id=3730d7ab97a78fdc13b9ea1cffca7e0ca2138a8dc8596e145bce054cf7f1dd0e"
    }
  },
  {
    "ts": null,
    "headline": "Tweedy, Browne Fund Q1 2025 Commentary",
    "summary": "As deep value managers, we remain disciplined in our approach, seeking out securities that trade at meaningful discounts to our conservative estimates of intrinsic value.",
    "url": "https://finnhub.io/api/news?id=603eba383d701484d3eb0782ee29fe6f8ac7a077e646365ac0ff99aa92dcc3bf",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746170700,
      "headline": "Tweedy, Browne Fund Q1 2025 Commentary",
      "id": 134183248,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2159126735/image_2159126735.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "As deep value managers, we remain disciplined in our approach, seeking out securities that trade at meaningful discounts to our conservative estimates of intrinsic value.",
      "url": "https://finnhub.io/api/news?id=603eba383d701484d3eb0782ee29fe6f8ac7a077e646365ac0ff99aa92dcc3bf"
    }
  },
  {
    "ts": null,
    "headline": "J&J-backed HistoSonics explores sale at $2.5 billion valuation, FT reports",
    "summary": "HistoSonics, a medical technologycompany backed by Johnson & Johnson, is exploring apotential sale at a valuation of more than $2.5 billion afterreceiving multiple takeover offers, the Financial...",
    "url": "https://finnhub.io/api/news?id=595752fd9785cf9c9a4892035bae81bb06405329357520ada79d67147fcd7e21",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746146338,
      "headline": "J&J-backed HistoSonics explores sale at $2.5 billion valuation, FT reports",
      "id": 134180603,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "HistoSonics, a medical technologycompany backed by Johnson & Johnson, is exploring apotential sale at a valuation of more than $2.5 billion afterreceiving multiple takeover offers, the Financial...",
      "url": "https://finnhub.io/api/news?id=595752fd9785cf9c9a4892035bae81bb06405329357520ada79d67147fcd7e21"
    }
  },
  {
    "ts": null,
    "headline": "JNJ-Backed Histosonics Is Pursuing A Sale After Fielding Takeover Bids, Seeking A Valuation Of More Than $2.5 Billion - FT",
    "summary": "May 2 - * JNJ-BACKED HISTOSONICS IS PURSUING A SALE AFTER FIELDINGTAKEOVER BIDS, SEEKING A VALUATION OF MORE THAN $2.5BN - FTSource text: https://tinyurl.com/3y4d5h63Further company...",
    "url": "https://finnhub.io/api/news?id=cecf9bfbdc9d7bb03fed751fc74339bc80b9931d82894bde4dcd6598d7f185e9",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746144372,
      "headline": "JNJ-Backed Histosonics Is Pursuing A Sale After Fielding Takeover Bids, Seeking A Valuation Of More Than $2.5 Billion - FT",
      "id": 134180391,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "May 2 - * JNJ-BACKED HISTOSONICS IS PURSUING A SALE AFTER FIELDINGTAKEOVER BIDS, SEEKING A VALUATION OF MORE THAN $2.5BN - FTSource text: https://tinyurl.com/3y4d5h63Further company...",
      "url": "https://finnhub.io/api/news?id=cecf9bfbdc9d7bb03fed751fc74339bc80b9931d82894bde4dcd6598d7f185e9"
    }
  }
]